journal cover

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

Vaccine

Sep 1, 1996

Ann R Falsey, Edward E Walsh

Abstract

The safety and immunogenicity of purified fusion protein (PFP-2) respiratory syncytial virus (RSV) vaccine was evaluated in a randomized placebo-controlled, double-blind study of 64 healthy adults over age 60. Vaccination was well tolerated with no significant acute side-effects. Twenty...read more

Mentioned in this Paper

Respiratory Syncytial Virus Infections
Viral Vaccines
Antibodies, Viral
Vaccination
Group B Streptococcal Pneumonia
Immunization Domain
Respiratory syncytial virus
Specialty Type - Ambulatory
F-protein
Fusion protein
21
Paper Details
References
  • References22
  • Citations56
12345...

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

Vaccine

Sep 1, 1996

Ann R Falsey, Edward E Walsh

PMID: 8961507

DOI: 10.1016/s0264-410x(96)00030-8

Abstract

The safety and immunogenicity of purified fusion protein (PFP-2) respiratory syncytial virus (RSV) vaccine was evaluated in a randomized placebo-controlled, double-blind study of 64 healthy adults over age 60. Vaccination was well tolerated with no significant acute side-effects. Twenty...read more

Mentioned in this Paper

Respiratory Syncytial Virus Infections
Viral Vaccines
Antibodies, Viral
Vaccination
Group B Streptococcal Pneumonia
Immunization Domain
Respiratory syncytial virus
Specialty Type - Ambulatory
F-protein
Fusion protein
21

Related Papers

Paper Details
References
  • References22
  • Citations56
12345...
/papers/safety-and-immunogenicity-of-a-respiratory/8961507